Invention Grant
- Patent Title: Antibodies to β2-glycoprotein I and therapeutic uses thereof
-
Application No.: US14903284Application Date: 2014-07-07
-
Publication No.: US09777057B2Publication Date: 2017-10-03
- Inventor: Francesco Tedesco , Pier Luigi Meroni , Daniele Sblattero
- Applicant: Onconox APS
- Applicant Address: DK Copenhagen, OT
- Assignee: ONCONOX APS
- Current Assignee: ONCONOX APS
- Current Assignee Address: DK Copenhagen, OT
- Agency: Silvia Salvadori, P.C.
- Agent Silvia Salvadori
- International Application: PCT/EP2014/064400 WO 20140707
- International Announcement: WO2015/004038 WO 20150115
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K39/00
Abstract:
Human recombinant antibodies or fragments thereof having specificity for the β2-glycoprotein I (β2GPI), pharmaceutical compositions containing same and use thereof in a method for treating or preventing thrombus formation and fetal loss in a patient affected by antiphospholipid syndrome (APS).
Public/Granted literature
- US20160152696A1 ANTIBODIES TO ß2-GLYCOPROTEIN I AND THERAPEUTIC USES THEREOF Public/Granted day:2016-06-02
Information query
